Summary:
Summary Statement of Deficiencies D2000 ENROLLMENT AND TESTING OF SAMPLES CFR(s): 493.801 Each laboratory must enroll in a proficiency testing (PT) program that meets the criteria in subpart I of this part and is approved by HHS. The laboratory must enroll in an approved program or programs for each of the specialties and subspecialties for which it seeks certification. The laboratory must test the samples in the same manner as patients' specimens. For laboratories subject to 42 CFR part 493 published on March 14, 1990 (55 FR 9538) prior to September 1, 1992, the rules of this subpart are effective on September 1, 1992. For all other laboratories, the rules of this subpart are effective January 1, 1994. This CONDITION is not met as evidenced by: Based on a review of the laboratory American Proficiency Institute (API) proficiency testing (PT) records and an interview with the laboratory manager, the laboratory failed to enroll in an approved program for Microbiology and Routine Chemistry for the 1st and 2nd testing events of 2020 and no other testing was performed to establish and maintain the accuracy of the testing procedures, in accordance with 493.1236 (c) (1). Findings: 1. A review of 2019 and 2020 API PT records identified no enrollment for Microbiology- Bacteriology PT of the Film Array BioFire GI panel, Respiratory panel, and Meningitis panel for testing events 1 and 2 of 2020. 2. A review of 2019 and 2020 API PT records identified no enrollment for Chemistry- Core Chemistry and Hematology PT of Respiratory Therapy testing pCO2, pH, pO2, Carboxyhemoglobin, Hemoglobin (Blood Oximetry), Methemoglobin, and Oxyhemoglobin for testing events 1 and 2 of 2020. 3. A review of the PT records for the API Microbiology and Core Chemistry 2020 testing events (1 and 2), identified an investigation and